Business description: Merck KGaA

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows:

- solutions and products for scientific and biotechnological research (44.2%);

- pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.;

- performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc.

Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).

Number of employees: 62,345

Sales by Activity: Merck KGaA

Fiscal Period: December20192020202120222023

Life Science

6.88B 7.53B 9.05B 10.44B 9.36B

Healthcare

6.71B 6.64B 7.09B 7.84B 8.05B

Electronics

2.57B 3.38B 3.61B 4.01B 3.66B

Corporate and Other

-21M -18M -62M -61M -77M
See all business segments

Geographical breakdown of sales: Merck KGaA

Fiscal Period: December20192020202120222023

USA

4.1B 4.64B 5.25B 6.3B 5.91B

Other Europe

3.37B 3.55B 4.03B 4.52B 4.4B

Asia-Pacific (Excluding China)

3.25B 3.74B 4.09B 4.48B 4.18B

China

2.05B 2.22B 2.55B 2.82B 2.48B

Germany

1.48B 1.5B 1.66B 1.53B 1.42B

Latin America

965M 868M 947M 1.18B 1.27B

Middle East and Africa (MEA)

373M 361M 404M 516M 535M

Switzerland

389M 462M 529M 592M 512M

North America (Excluding USA)

182M 191M 225M 294M 287M
See all geographic segments

Managers: Merck KGaA

Insider TitleAgeSince
Chief Executive Officer 63 12/07/20
Director of Finance/CFO 54 25/04/19
Investor Relations Contact - -
Corporate Officer/Principal - 31/12/05
Corporate Officer/Principal 58 31/12/88
See MERCK KGAA governance

Members of the board: Merck KGaA

Insider TitleAgeSince
Director/Board Member - -
Director/Board Member 61 30/04/12
Director/Board Member 75 08/05/14
Composition of the Board of Directors

Shareholders: Merck KGaA

NameEquities%Valuation
Massachusetts Financial Services Co.
5.058 %
6,536,955 5.058 % 1 084 M €
DWS Investment GmbH
2.946 %
3,806,894 2.946 % 631 M €
MFS International Singapore Pte Ltd.
1.635 %
2,113,628 1.635 % 351 M €
Amundi Asset Management SA (Investment Management)
0.8946 %
1,156,208 0.8946 % 192 M €
MFS International (UK) Ltd.
0.8028 %
1,037,535 0.8028 % 172 M €
NameEquities%Valuation
305,535,626 100.00 % 50 674 M €
NameEquities%Valuation
Manulife Investment Management Ltd.
0.0566 %
365,707 0.0566 % 12 M €
Henry James International Management, Inc.
0.0109 %
70,205 0.0109 % 2 M €
MAI Capital Management LLC
0.004055 %
26,201 0.004055 % 869 113 €
Domini Impact Investments LLC
0.003374 %
21,800 0.003374 % 723 128 €
Yousif Capital Management LLC
0.001715 %
11,085 0.001715 % 367 701 €
List of MERCK KGAA shareholders

Holdings: Merck KGaA

NameEquities%Valuation
2,787,509 4.43% 122,566,771 $
388,194,920 86.65% 94,113,976 $
1,913,501 3.50% 69,230,466 $
20,647,152 8.18% 32,622,500 $

Company details: Merck KGaA

Merck KGaA

Frankfurter Strasse 250

64293, Darmstadt

+49 6151 72 0

http://www.merckgroup.com/de
address Merck KGaA(MRK)

Group companies: Merck KGaA

NameCategory and Sector
Ridgefield Holdco SARL
Chemicals: Specialty
Pharmaceuticals: Other
Merck Capital Ltd.
Merck Invest SCS
See all subsidiaries

Specialty & Advanced Pharmaceuticals

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.19%+1.80%-1.08%-9.63% 73.15B
-1.05%-1.55%+15.05%-16.57% 10.84B
+1.03%+1.24%+55.83%+83.79% 5.3B
+1.43%-0.12%+0.47%-30.33% 4.83B
-5.86%-14.28%+30.95%+128.24% 2.99B
-1.16%-3.16%+10.02%+24.69% 2.21B
+2.34%-0.19%-39.29%-67.17% 1.82B
+2.14%+6.63%+2.48%+13.29% 1.67B
-.--%-.--% - - 1.64B
-5.87%-9.87%-54.92%-69.69% 1.56B
Average -0.77%-2.44%+2.17%+6.29% 10.6B
Weighted average by Cap. -0.26%-0.47%+3.29%-3.42%
See all sector performances